Lv6
1700 积分 2025-05-11 加入
Case Report: Telitacicept for interstitial lung disease associated with idiopathic inflammatory myopathies: an observational study
15天前
已完结
Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study
15天前
已完结
Telitacicept add-on therapy in refractory idiopathic inflammatory myopathy: insights from a pilot study
15天前
已完结
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review
15天前
已完结
Advances in the classification and management of idiopathic inflammatory myopathies
30天前
已完结
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome
2个月前
已完结
CD19-targeted CAR T cells in refractory antisynthetase syndrome
3个月前
已完结
Janus kinase inhibition (JAKi) therapy in refractory anti-synthetase syndrome: A retrospective cohort study
3个月前
已完结
Teclistamab-induced rapid remission in refractory Anti-Jo-1 Antisynthetase Syndrome
3个月前
已完结
Interleukin 6 inhibition in refractory antisynthetase syndrome: case-based literature review
3个月前
已完结
皖公网安备34019202002308
